IMPROVE-IT2 is a randomized multicenter trial comparing the outcomes of ctDNA guided post-operative surveillance and standard-of-care CT-scan surveillance. The hypothesis of this study is that ctDNA g
PI live movies of all patients in group B (single stent). The PI sequence was also displayed live during the measurements. The recorded PI images were later used (together with other data) to determin
